Items where authors include "Rédini, F."
Article
Jacques, C., Lamoureux, F., Baud'huin, M. et al. (8 more authors) (2016) Targeting the epigenetic readers in Ewing Sarcoma inhibits the oncogenic transcription factor EWS/Fli1. Oncotarget. ISSN 1949-2553
Ando, K., Heymann, M.F., Stresing, V. et al. (3 more authors) (2013) Current Therapeutic Strategies and Novel Approaches in Osteosarcoma. Cancers, 5 (2). pp. 591-616. ISSN 2072-6694
Heymann, D. orcid.org/0000-0001-7777-0669 and Rédini, F. (2013) Targeted therapies for bone sarcomas. BoneKEy Reports, 2. 378. ISSN 2047-6396
Ando, K., Mori, K., Verrecchia, F. et al. (3 more authors) (2012) Molecular Alterations Associated with Osteosarcoma Development. Sarcoma, 2012. 523432. ISSN 1357-714X
Heymann, D. orcid.org/0000-0001-7777-0669 and Rédini, F. (2011) Bone sarcomas: pathogenesis and new therapeutic approaches. IBMS BoneKEy, 8 (9). pp. 402-414. ISSN 1940-8692
David, E., Blanchard, F., Heymann, M.F. et al. (4 more authors) (2011) The Bone Niche of Chondrosarcoma: A Sanctuary for Drug Resistance, Tumour Growth and also a Source of New Therapeutic Targets. Sarcoma, 2011. 932451. ISSN 1357-714X
Ando, K., Mori, K., Rédini, F. et al. (1 more author) (2008) RANKL/RANK/OPG: key therapeutic target in bone oncology. Current Drug Discovery Technologies, 5 (3). pp. 263-268. ISSN 1570-1638
Ory, B., Moriceau, G.D., Trichet, V. et al. (5 more authors) (2008) Farnesyl diphosphate synthase is involved in the resistance to zoledronic acid of osteosarcoma cells. J Cell Mol Med, 12 (3). pp. 928-941. ISSN 1582-1838